ANGPT1 and fetal growth restriction: This is in contrast to the study by Leinonen et al that examined the circulating levels of Ang-1, Ang-2 and Tie-2 at 12–15 or 16–20 gestational weeks in 16 women with subsequent isolated IUGR compared to 59 healthy women served as controls (37).